Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Merck & Co. initiates phase IIb clinical trial of SurModics' I-vation intravitreal implant

June 30, 2008

FDA approves Sirion's NDA for Durezol in postoperative ocular inflammation and pain

June 27, 2008

Allergan patents novel prostanoid EP2 agonist prodrugs

June 20, 2008

Inotek begins a phase I trial of INO-8875 for the treatment of glaucoma

June 20, 2008

Allergan receives FDA approval for Trivaris for ophthalmic indications

June 17, 2008

Opko Health acquires exclusive worldwide rights to Redox's Doxovir for viral conjunctivitis

June 17, 2008

Akorn receives FDA approvable letter for Akten ophthalmic gel 3.5%

June 10, 2008

Recent Devgen patent discloses novel agents for glaucoma

June 9, 2008

Santen enters agreement in Japan and Asia with MacuSight for sirolimus

June 6, 2008

Santen files Japanese manufacturing and marketing approval applications for DE-089

June 6, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...